Haleon PLC

Board/Management Information • Mar 9, 2023

National Storage Mechanism | Additional information

RNS Number : 4853S

Haleon PLC

09 March 2023

Haleon plc: Establishment of Environmental and Social Sustainability Committee

9 March 2023: Haleon plc (the "Company") (LSE/NYSE: HLN) today announces that with effect from today, the Board has established the Environmental and Social Sustainability Committee (the "Committee"). The role of the Committee is to provide oversight and effective governance over progress with the environmental and social sustainability agenda of the Company and the external governance and regulatory requirements relevant to these areas.

The members of the Committee, all of whom are independent Non-Executive Directors of the Company, are Marie-Anne Aymerich (Chair of the Committee), Tracy Clarke and Dame Vivienne Cox.

Further information about the governance arrangements of the Company and the Terms of Reference of the Committee are available at www.haleon.com.

This announcement is made in accordance with Listing Rule 9.6.11.

Amanda Mellor 

Company Secretary 

About Haleon

Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com.  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCKZGGFDLGGFZM